LifeMD, Inc. (LFMDP) has a negative trailing P/E of -27.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 299.2 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -3.68%, forward earnings yield 0.33%. PEG 1.20.
Criteria proven by this page:
Overall SharesGrow Score: 54/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -8.3 | -0.01 | -25.80 | 1.75 | - |
| 2017 | -12.4 | 0.99 | 16.95 | 2.96 | - |
| 2018 | -5.0 | 0.00 | 6.89 | 0.74 | - |
| 2019 | -1.9 | -0.01 | -6.01 | 0.48 | - |
| 2020 | -1.6 | 0.00 | 68.85 | 2.50 | 1.38% |
| 2021 | -1.7 | 0.04 | 3.89 | 1.13 | 0.83% |
| 2022 | -1.3 | 0.04 | -8.80 | 0.50 | 5.17% |
| 2023 | -13.6 | 0.26 | 80.18 | 1.84 | 1.11% |
| 2024 | -10.8 | 0.44 | -37.17 | 0.96 | 1.52% |
| 2025 | -21.7 | 0.38 | 6.65 | 0.79 | 2.02% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-0.16 | $5.24M | $-1.11M | -21.1% |
| 2017 | $-0.14 | $5.05M | $-1.21M | -23.9% |
| 2018 | $-0.14 | $8.32M | $-1.24M | -14.9% |
| 2019 | $-0.36 | $12.47M | $-3.53M | -28.3% |
| 2020 | $-4.24 | $37.29M | $-60.52M | -162.3% |
| 2021 | $-2.27 | $92.88M | $-61.32M | -66% |
| 2022 | $-1.45 | $119.03M | $-45.02M | -37.8% |
| 2023 | $-0.70 | $152.55M | $-20.6M | -13.5% |
| 2024 | $-0.53 | $212.45M | $-18.88M | -8.9% |
| 2025 | $-0.23 | $194.06M | $-7.11M | -3.7% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.20 | $-0.21 – $-0.19 | $223.34M | $221.6M – $225.68M | 1 |
| 2027 | $0.08 | $0.08 – $0.08 | $265.23M | $244.2M – $282.51M | 1 |
| 2028 | $0.28 | $0.26 – $0.29 | $295.9M | $282.11M – $307.79M | 1 |
